P-108 Infliximab-Associated Suppression of Cytokine Release by Mucosal Explants Predicts Success of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.